Opinion
Weekly Trust on MSNOpinion

How to develop North's economy - Mohammed Hayatu-Deen

Deen, a former Group Managing Director (GMD) of Northern Nigerian Development Company (NNDC) and former Chief Executive Officer (CEO) of FSB International Bank, is well known in the corporate world ...
Daylight Saving Time ends on Nov. 2, the first Sunday of November. Clocks will be set back one hour, making sunrise and sunset each an hour earlier.
The Ukrainian President arrives at the White House Friday with a wish-list including Tomahawks—and he may get them, writes ...
Constellation Software (TSX:CSU) and another great tech stock still worth buying up in this volatile month. The post 2 Stocks I Like Better Than Shopify at Today’s Price appeared first on The Motley ...
Discover five everyday financial habits that drain your savings, according to one money expert. Learn how to flip them into ...
We’re seeing a budget crisis in our local city-run entities, like the Bemidji Public Library and the Historical Society. Soon ...
Sarah has been an editor and contributor for Game Rant since 2015. After meeting her first Chocobo, she never looked back. Sarah majored in game design in college and utilizes that knowledge to ...
iOS 26.0.1 just arrived this week, but the next more substantive iPhone update coming is iOS 26.1. It’s in beta testing now, but a public launch isn’t far off. Here’s the expected iOS 26.1 release ...
The NCAA's FBS Oversight Committee approved a modification Monday to its new January transfer window that will allow undergraduate and postgraduate players to enter the transfer portal from Jan. 2-16.
Tempus AI (NASDAQ: TEM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, ...
UNDATED (WKRC) - ALDI announced it's launching its largest packaging refresh to date, introducing its first-ever namesake brand to enhance the recognition of its private labels. The initiative, driven ...
During the last three months, 12 analysts shared their evaluations of Apellis Pharmaceuticals (NASDAQ: APLS), revealing diverse outlooks from bullish to bearish. The table below summarizes their ...